Naturally gluten-free foods
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
Why do I sweat so much?
Walking pneumonia: The "mild" illness that can still pack a punch
What causes knee pain: How doctors make a diagnosis
Where you carry excess weight matters in predicting heart disease risk
Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?
Healthy aging and longevity
Immunotherapy: What you need to know
Naturally gluten-free foods
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
Why do I sweat so much?
Walking pneumonia: The "mild" illness that can still pack a punch
What causes knee pain: How doctors make a diagnosis
Where you carry excess weight matters in predicting heart disease risk
